本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Theravance Biopharma Inc.

10.12
-0.2550-2.46%
成交量:3.08万
成交额:31.40万
市值:5.06亿
市盈率:-8.76
高:10.41
开:10.41
低:10.11
收:10.37
数据加载中...
2020/06/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/10

重要事件披露

8-K - Current report
2020/05/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/29

重要事件披露

8-K - Current report
2020/04/09

重要事件披露

Current report, items 8.01 and 9.01
2020/03/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/03/03

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/24

重要事件披露

Current report, items 2.02 and 9.01
2020/02/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/13

重要事件披露

Current report, items 1.01, 2.02, 8.01, and 9.01
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

重要事件披露

Current report, item 5.02
2020/01/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals